Global Breast Tomosynthesis Market – Industry Trends and Forecast to 2029

Global Breast Tomosynthesis Market, By Product (2D/3D Combination Systems, Standalone 3D Systems), End User (Hospitals, Diagnostic Centres, Others) – Industry Trends and Forecast to 2029

Market Analysis and Size

As per the World Health Organization (WHO), in 2018, breast cancer afflicted around 627,000 women worldwide, with the illness occurrence is expected to be higher in developed than developing regions. Because disease screening using DBT is far more convenient and efficient than screening with a 2D mammography, demand for such products is predicted to rise between 2022 and 2029.

Data Bridge Market Research analyses that the breast tomosynthesis market which was USD 2.04 billion in 2021, would rocket up to USD 5.46 billion by 2029, and is expected to undergo a CAGR of 13.10% during the forecast period 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Digital Breast tomosynthesis (DBT) mammography (sometimes known as "3D" mammography) is a form of mammography that has been increasingly popular in recent years. It's an x-ray imaging exam that takes numerous photographs of the breast. The breast is crushed in the same way as it would be in a normal mammography. The x-ray tube moves in an arc around the breast, collecting images from various angles. The x-ray images are shown as a stack of mammography images for the radiologist to read.

Report Scope and Market Segmentation

Breast Tomosynthesis Market Dynamics

Drivers

• Increase the detection of breast cancer

Normal breast tissue can mask breast cancer, but DBT can help locate it since it takes mammography images from several angles. On mammography, overlaying normal breast tissue can also appear suspicious. DBT mammography has the potential to reduce tissue overlap and reduce the requirement for patients to return for additional imaging. New and improved technology is offering even more profitable market opportunities.

• Rise in the use of tomosynthesis

Cutting-edge technology development is expected to fuel the digital breast tomosynthesis market's expansion. Furthermore, the global increase in the incidence of breast cancer is expected to slow the growth of the digital breast tomosynthesis market. On the other side, the increased radiation exposure during the procedure is expected to stifle the growth of the digital breast tomosynthesis market.

• Increase in prevalence of breast cancer

The global breast tomosynthesis market will be driven by an increase in the usage of digital breast tomosynthesis devices by various healthcare providers as a primary source of detection of breast cancer, particularly in the dense breast, during the projected period. Increased mammography screening for breast cancer diagnosis across the globe is also expected to boost the global breast tomosynthesis market.

Opportunities

In addition, the advancement of three-dimensional mammography technology for early cancer diagnosis will give more prospects for the breast tomosynthesis market to grow in the coming years. However, the rising cost of operations and labour scarcity for these sophisticated procedures may pose a significant obstacle to the digital breast tomosynthesis market's growth in the near future.

DBT machines, in compared to standard 2D mammography, have higher sensitivity and specificity, which minimises false-positive recalls and improves cancer diagnosis, particularly invasive cancer detection. DBT minimises the need for further breast imaging by 15%, lowering expenditures, psychological suffering, time, and pain associated with a false negative recall.

Restraints/Challenges

• High cost of the equipment

The availability of alternatives will be major restraints on the worldwide digital breast tomosynthesis market. DBT has a number of potential restrictions and practical disadvantages. Increased radiation doses, longer scan times, longer reading times, and other dangers may be associated with using DBT. Such issues are likely to stifle growth.

• Interpretations of mammograms can be difficult

If you had breast surgery, the appearance of an image can be difficult. Because certain breast tumours are difficult to see, a radiologist might want to compare the image to previous scans. It's critical to remember that not all breast cancers can be detected by mammography. While mammography is the most effective breast cancer screening technology available today, it does not identify all breast cancers. A false-negative result is what this is known as. On the other hand, a false-positive result occurs when a mammography appears suspicious but no cancer is present.

This breast tomosynthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the breast tomosynthesis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Breast Tomosynthesis Market

COVID-19 is an unparalleled global public health disaster that has impacted virtually every industry. Our ongoing research improves our research strategy to ensure that core COVID-19 challenges and potential solutions are addressed. The study looks at COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government engagement. The updated study evaluates the market impact of COVID-19 and provides insights, analyses, predictions, and forecasts.

Recent Development

• In January 2021, the company has expanded its ultrasound portfolio with the advent of the SuperSonic MACH 20 ultrasound machine. In the same month, Hologic stated that 3D ultrasound imaging would be available on the SuperSonic MACH 30 and 20 ultrasound systems in Europe. This breakthrough, which allows customers to access high-resolution B-mode and ShearWave PLUS elastography 3D volumes, is likely to have seen widespread adoption in the quarter ahead.
• Hologic’s SuperSonic MACH 40 ultrasound system (which is equipped with 3D ultrasound imaging since December 2020) and other significant contributors to divisional sales for the fiscal second quarter are estimated to have included its upgraded Unifi Analytics platform (available as Unifi Analytics 1.2 since November 2020). After its commercial launch in Europe in October 2020, Hologic is anticipated to have continued to benefit from its 3DQuorum Imaging Technology, which Genius AI powers.

Global Breast Tomosynthesis Market Scope

The breast tomosynthesis market is segmented on the basis of product and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• 2D/3D Combination Systems
• Standalone 3D Systems

End-User

• Hospitals
• Diagnostics Centers
• Others

Breast Tomosynthesis Market Regional Analysis/Insights

The breast tomosynthesis market is analysed and market size insights and trends are provided by country, product and end user as referenced above.

The countries covered in the breast tomosynthesis  market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the rising prevalence of breast cancer, the digital breast tomosynthesis market is expected to grow. Furthermore, rising healthcare costs would propel the digital breast tomosynthesis market in the region even faster throughout the forecast period of 2022 to 2029.

Asia-Pacific is projected to observe a significant amount of growth in the digital breast tomosynthesis market due to the incidence of major key players in evolving countries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The breast tomosynthesis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast tomosynthesis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast tomosynthesis market. The data is available for historic period 2010-2020.

Competitive Landscape and Breast Tomosynthesis Market Share Analysis

The breast tomosynthesis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to breast tomosynthesis market.

Some of the major players operating in the breast tomosynthesis market are:

• Siemens (Germany)
• Hologic, Inc. (MA)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Abbott (U.S.)
• BD (NJ)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Shimadzu Medical (India) pvt. Ltd. (Japan)
• GENERAL ELECTRIC (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Sysmex India Pvt. Ltd. (Japan)
• Hitachi, Ltd. (Japan)
• Canon Inc. (Japan)
• FUJIFILM Holdings Corporation (U.K)